ArticleFrontiers in oncology2023

Efficacy and feasibility of Apatinib and S-1 as a novel oral induction therapy in locally advanced head and neck squamous cell carcinoma: an exploratory phase 2 open-label, single-arm trial.

Wen Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.